Guided Therapeutics

Guided Therapeutics News

	Guided Therapeutics, Inc. New Stock Ticker Symbol - GTHP Guided Therapeutics, Inc. and Konica Minolta Look to Expand Cancer Detection Technology
	Agreement Signed to Manufacture New Non-invasive Cancer Detection Devices
	New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
	Pre-PMA Meetings Held with FDA on Painless Cervical Cancer Test
	Painless Cancer Test May Eliminate Half of Unnecessary Cervical Biopsies
	Two Clinical Studies Indicate SpectRx (Guided Therapeutics) Non-invasive Cervical Cancer Detection Device Accurately Detects Disease While Reducing False Positive Results
	SpectRx, Inc. (Guided Therapeutics) Granted Patent for Non-invasive Cervical Cancer Detection Technology
	SpectRx, Inc. (Guided Therapeutics) Successfully Builds and Tests First Pre-production Non-invasive Cervical Cancer Detection Device
	SpectRx, Inc. (Guided Therapeutics) Granted Key Patent for Non-invasive Cervical Cancer Detection Technology
	Emory and (Guided Therapeutics) SpectRx, Inc. Partner in Georgia Research Alliance Innovation Fund Project for Clinical Trials of Non-invasive Cervical Cancer Detection Device

	(Guided Therapeutics) SpectRx, Inc. Selected for an Additional $1.1 Million Grant by National Cancer Institute for Non-invasive Cervical Cancer Detection Technology
	(Guided Therapeutics) SpectRx, Inc. Begins Initial Phase of FDA Pivotal Clinical Trial for Non-invasive Cervical Cancer Detection Test
	(Guided Therapeutics) SpectRx Completes National Cancer Institute Clinical Trial of Non-invasive Cervical Cancer Test
	Published Study Shows 81% of Women Want SpectRx Non-invasive Cervical Cancer Test to Replace Pap Test

4955 Avalon Ridge Parkway

Suite 300

Norcross, GA 30071

770-242-8723

770-242-8639 - Fax

www.guidedtherapeutics.com

info@guidedtherapeutics.com

cervical cancer, cervical cancer vaccine, spectrx, HPV, Pap test, pap smear, Human Papilloma virus, Human Papillomavirus, noninvasive, non-invasive, cancer detection, cancer products